Recombinant Anti-CD45 x Anti-Myosin Bispecific Antibody (IgG(L)-scFv) (IGLFV-122)

Recombinant Anti-CD45 x Anti-Myosin Bispecific Antibody (IgG(L)-scFv) is formed by an IgG and two scFv moieties. The scFv fragments from an anti-CD45 antibody are fused to the C terminus of an anti-Myosin IgG light (L) chains, or vice versa. It is a type of appended IgGs, which is bispecific and tetravalent (2+2 antigen-binding valency). This BsAb can recruit stem cells to infarcted myocardium. It is designed for the research of Myocardial infarction therapy.

Datasheet INQUIRY

Specifications

Targets

CD45 & Myosin

Type

Appended IgGs

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Myocardial infarction

Targets

Target 1

CD45

Gene ID

5788

UniProt ID

P08575

Alternative Names

PTPRC; CD45; Cluster of differentiation 45; protein tyrosine phosphatase, receptor type C; LCA; LY5; B220; CD45; L-CA; T200; CD45R; GP180

Target 2

Myosin

Alternative Names

Myosin; ATP-dependent motor proteins

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD45 x Anti-Myosin Bispecific Antibody (IgG(L)-scFv) (IGLFV-122). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-CD45 x Anti-Myosin Bispecific Antibody (IgG(L)-scFv) (CAT#: IGLFV-122)

Specifications

Targets

Customer Reviews and Q&As